December 25, 2024 09:58 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Former home secy Ajay Kumar Bhalla appointed Manipur Guv amid ethnic violence resurgence | Five soldiers killed, several injured as Army truck falls into Poonch gorge | Allu Arjun quizzed by police in Pushpa 2 stampede case | Wanted Indian drug smuggler killed in the US | Congress leader files complaint against Allu Arjun for 'insulting police' in Pushpa 2: The Rule | Ahead of Jaishankar's US visit, foreign secretary Vikram Misri meets top US diplomats | India refrains from commenting on extradition request for ousted Bengladeshi PM Sheikh Hasina | I don't blame Allu Arjun, ready to withdraw case: Pushpa 2 stampede victim's husband | Indian New Wave Cinema Architect Shyam Benegal dies at age 90 | Cylinder blast at a temple in Karnataka's Hubbali injures nine people
Mukesh Ambani

Mukesh Ambani Asia's richest again after China's Zhong Shanshan loses $22 billion in net worth

| @indiablooms | Feb 27, 2021, at 05:35 pm

Mumbai/IBNS: Mukesh Ambani is once again Asia's richest man after China's Zhong Shanshan's networth fell more than $22 billion, reported Bloomberg.

According to the report, Ambani's Reliance Industries Ltd remained relatively unaffected even as it announced that its oil-to-chemical business will be spinned off as a separate unit amid a brutal week for the markets.

After Zhong Shanshan's bottled water company lost a record 20% this week, his net worth slipped to $76.6 billion, down more than $22 billion from a peak just last week, according to the Bloomberg Billionaires Index, said the report cited above.

Ambani's net worth now is nearly $80 billion. He had taken over from Alibaba Group Holding Ltd.'s Jack Ma. Following the listing of Zhong's two companies, he replaced Ambani at the end of December and by early 2021 he became the sixth wealthiest person in the world, surpassing Warren Buffet.

Zhong's two companies--Nongfu Spring Co. more than tripled from its initial public offer reaching its peak in January while his Beijing Wantai Biological Pharmacy Enterprise Co., jumped as much as 3,757%, the Bloomberg report stated.

The rise of the two companies came to a grinding halt as the Hong Kong and Chinese stock markets witnessed the biggest decline. With the plunge, Nongfu shares lost the gains made for the year, while Wantai's suffered the biggest monthly loss ever.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.